In NOD mice, the onset of diabetes is significantly delayed by reducing the level of CXCL12 either by antibody-mediated neutralization or G-CSF-induced suppression of CXCL12 transcription [13-16]. The gene discussed is CXCL12; the disease is diabetes mellitus.